RT Journal Article
SR Electronic
T1 To pool or not to pool samples for Sexually Transmitted Infections detection in Men who have Sex with Men? An evaluation of a novel pooling method using the GeneXpert instrument in West-Africa (CohMSM-PrEP ANRS 12369 – Expertise France)
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.01.22.20017392
DO 10.1101/2020.01.22.20017392
A1 De Baetselier, Irith
A1 Vuylsteke, Bea
A1 Yaya, Issifou
A1 Dagnra, Anoumou
A1 Diandé, Souba
A1 Yaka, Jeff
A1 Kadanga, Gérard
A1 Traore, Issa
A1 Cuylaerts, Vicky
A1 Smet, Hilde
A1 Dah, Elias
A1 Mensah, Ephrem
A1 Anoma, Camille
A1 Koné, Amadou
A1 Fayé-Ketté, Hortense
A1 Yeo, Alain
A1 Keita, Bintou Dembélé
A1 Laurent, Christian
A1 Crucitti, Tania
A1 for the CohMSM-PrEP study group
YR 2020
UL http://medrxiv.org/content/early/2020/01/27/2020.01.22.20017392.abstract
AB Background Men who have sex with Men (MSM) using Pre-exposure prophylaxis (PrEP) are at risk for Sexually Transmitted Infections (STIs). Therefore, PrEP services should include regular screening for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) at urethra, anorectum and pharynx. However, financial and logistic challenges arise in low resource settings. We assessed a novel STI sample pooling method using the GeneXpert instrument among MSM initiating PrEP in West-Africa.Methods Urine, anorectal and pharyngeal samples were pooled per individual for analysis. Unpooled samples were analyzed in case of an invalid or positive result of the pool, to identify the infection’s biological location. The results of two different pooling strategies were compared against a gold standard.Results We found a prevalence of 14.5% for chlamydia and 11.5% for gonorrhea, with a predominance of infections being extra-genital (77.6%). The majority of infections were asymptomatic (88.2%). The pooling strategy with unpooling of invalid results only, had a sensitivity, specificity and agreement for CT of 95.4%, 98.7% and 0.93, respectively; and 92.3%, 99.2% and 0.93 with additional unpooling of positive results. For NG, these figures were 88.9%, 97.7% and 0.85 for testing of invalid results, and 88.9%, 96.7% and 0.81 with unpooling of positive results.Conclusion West-African MSM have a high prevalence of extra-genital and asymptomatic STIs. The GeneXpert method provides an opportunity to move from syndromic towards etiological STI diagnosis in low income countries, as the platform is available in all African countries for tuberculosis testing. Pooling will reduce costs of triple site testing.KeypointsA pooling strategy using GeneXpert had a sensitivity of 95.4% and 88.9% and a specificity of 98.7% and 97.7%, for CT and NG respectivelyMost CT/NG infections were of extra-genital origin (77.6%)The majority of CT/NG infections were asymptomatic (88.2%)Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by Expertise France (Initiative 5%) and France Recherche Nord & Sud Sida-hiv Hépatites (ANRS 12369). Cepheid provided the Xpert CT/NG cartridges according to the HBDC program.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data supporting the findings of this publication are retained at the Institute of Tropical Medicine (ITM), Antwerp and will not be made openly accessible due to ethical and privacy concerns. Data can however be made available after approval of a motivated and written request to the ITM at ITMresearchdataaccess{at}itg.be. The ITM data access committee will verify if the dataset is suitable for obtaining the study objective and assure that confidentiality and ethical requirements are in place.